Dihydroabikoviromycin, with the CAS number 38704-36-8, is a natural product belonging to the class of antibiotics known as macrolides. It is derived from the fermentation of specific strains of bacteria, particularly those in the genus Streptomyces. This compound exhibits a complex polycyclic structure, which is characteristic of many macrolides, contributing to its biological activity. Dihydroabikoviromycin has been studied for its antimicrobial properties, particularly against various strains of bacteria, making it of interest in the field of medicinal chemistry. Its mechanism of action typically involves inhibition of protein synthesis by binding to the bacterial ribosome. Additionally, like other macrolides, it may exhibit a range of pharmacological effects, including anti-inflammatory and immunomodulatory activities. The compound's solubility, stability, and bioavailability are important factors that influence its therapeutic potential. Research continues to explore its efficacy and safety profile, as well as its potential applications in treating bacterial infections and other diseases.

dihydroabikoviromycin

38704-36-8: Dihydroabikoviromycin, with the CAS number 38704-36-8, is a natural product belonging to the class of antibiotics known as macrolides. It is derived from the fermentation of specific strains of bacteria, particularly those in the genus Streptomyces. This compound exhibits a complex polycyclic structure, which is characteristic of many macrolides, contributing to its biological activity. Dihydroabikoviromycin has been studied for its antimicrobial properties, particularly against various strains of bacteria, making it of interest in the field of medicinal chemistry. Its mechanism of action typically involves inhibition of protein synthesis by binding to the bacterial ribosome. Additionally, like other macrolides, it may exhibit a range of pharmacological effects, including anti-inflammatory and immunomodulatory activities. The compound's solubility, stability, and bioavailability are important factors that influence its therapeutic potential. Research continues to explore its efficacy and safety profile, as well as its potential applications in treating bacterial infections and other diseases.

<p>Dihydroabikoviromycin is a secondary metabolite of Streptomyces anulatus and acts as a polyketide synthase inhibitor.</p>

CAS 38704-36-8

dihydroabikoviromycin

Dihydroabikoviromycin

Ref: TM-TN10209